By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – The third day of the JP Morgan Healthcare Conference featured several molecular diagnostics companies covered by GenomeWeb Daily News, as well as well-established tool firms Affymetrix and PerkinElmer.

Below are capsules from the third day of the conference.

Quidel

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.